ELICIO THERAPEUTICS INC (ELTX) Stock Cash Flow
NASDAQ:ELTX - Nasdaq - US28657F1030 - Common Stock - Currency: USD
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -38.66M | -35.20M | -38.81M | -54.57M | -80.11M | |||
| Depreciation Amortization | 334.00K | 382.00K | 180.00K | 90.00K | 100.00K | |||
| Change In Working Capital | 1.65M | -57.00K | -4.23M | -25.97M | 25.77M | |||
| Interest Paid | N/A | N/A | 0.00 | 10.00K | N/A | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 558.00K | 2.18M | 4.47M | 27.81M | 31.35M | |||
| OPERATING CASH FLOW | -36.13M | -32.69M | -38.39M | -52.64M | -22.89M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -88.00K | -66.00K | 0.00 | -380.00K | -40.00K | |||
| Other Investing Activity | 7.00K | 34.00K | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | -81.00K | -32.00K | 0.00 | -380.00K | -40.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 0.00 | 10.00M | -60.00K | 290.00K | 32.12M | |||
| Stock Issued/Repurchased | 18.40M | 6.98M | 0.00 | -620.00K | 20.81M | |||
| Other Financing Activity | N/A | 21.64M | 0.00 | 107.50M | -520.00K | |||
| FINANCING CASH FLOW | 18.40M | 38.61M | -60.00K | 107.17M | 52.41M | |||
| Exchange Rate Effect | N/A | 0.00 | 180.00K | 0.00 | -440.00K | |||
| CHANGE IN CASH | -17.85M | 5.89M | -38.27M | 54.15M | 29.04M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -36.13M | -32.69M | -38.39M | -52.64M | -22.89M | |||
| Capital Expenditure | -88.00K | -66.00K | 0.00 | -380.00K | -40.00K | |||
| FREE CASH FLOW | -36.22M | -32.76M | -38.39M | -53.02M | -22.93M | |||
All data in USD